Related Experiment Video

Updated: Aug 5, 2026

Assessing Replication and Beta Cell Function in Adenovirally-transduced Isolated Rodent Islets
09:31

Assessing Replication and Beta Cell Function in Adenovirally-transduced Isolated Rodent Islets

Published on: June 25, 2012

The Potential Target Value of ADP-Ribosylation Factor 6 in Insulin Secretion Regulation and the Treatment of

Yangyang Wang1

  • 1Jilin Collaborative Innovation Center for Antibody Engineering, Jilin Medical University, Jilin 132013, China.

Metabolites
|July 27, 2026
PubMed

Insights

ADP-ribosylation factor 6 (ARF6) hyperactivation impairs pancreatic beta-cell function, driving obesity and type 2 diabetes. Targeting ARF6 offers a novel therapeutic strategy for metabolic diseases.

Area of Science:

  • Metabolic diseases
  • Cellular signaling
  • Endocrinology

Background:

  • Obesity and type 2 diabetes mellitus (T2DM) are pandemic metabolic diseases characterized by impaired pancreatic beta-cell function and insulin release.
  • ADP-ribosylation factor 6 (ARF6), a small GTPase, regulates critical cellular processes including vesicle trafficking, cytoskeleton remodeling, and lipid metabolism.

Purpose of the Study:

  • To review the role of ARF6 in beta-cell function and its connection to obesity and T2DM.
  • To explore the therapeutic potential of targeting ARF6 for metabolic disease management.

Main Methods:

  • Literature review of ARF6's cellular functions and its involvement in beta-cell pathophysiology.
  • Analysis of existing data on ARF6 signaling cascades (e.g., Cdc42/Rac1) in the context of metabolic diseases.
  • Examination of the interplay between ARF6 and current anti-diabetic pharmacotherapies (e.g., GLP-1 receptor agonists, metformin, SGLT2 inhibitors).

Main Results:

  • ARF6 hyperactivation leads to beta-cell dysfunction, mitochondrial impairment, suppressed autophagy, and increased inflammation, exacerbating obesity and T2DM.
  • ARF6 acts as a key regulator of glucose-stimulated insulin secretion (GSIS).
  • Current therapeutics partially restore metabolic homeostasis by modulating ARF6-dependent signaling.

Conclusions:

  • ARF6 plays a critical role in beta-cell failure and metabolic deterioration associated with obesity and T2DM.
  • Targeting ARF6 presents a promising therapeutic avenue for managing metabolic diseases.
  • Further research is needed to fully elucidate ARF6's mechanisms and its translational potential.
Keywords:
ADP-ribosylation factor 6insulin secretionmetabolic disordersobesitytype 2 diabetes mellitus

More Related Videos

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function09:20

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function

Published on: May 4, 2021

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...